Home › Research › Health systems and care delivery
Changes to Medicare Advantage Risk Adjustment and Dementia Diagnosis in Older Adults
Sidra Haye, Mireille Jacobson, Geoffrey Joyce, Julie Zissimopoulos. Alzheimer s & Dementia, 2024-12-01
Topic: Risk, prevention and care in population studies
Abstract Background Diagnosing dementia supports patients’ access to treatment options and social services. The addition of dementia to the risk adjustment model for Medicare Advantage (MA) plan payments, affecting claims beginning in 2019, provided an incentive for MA plans to improve the detection and diagnosis of dementia among their enrollees. The objective of this project is to examine the changes in annual incident dementia diagnoses rates associated with the inclusion of dementia diagnoses in risk adjustment models for Medicare Advantage. Methods We conducted a retrospective study using 2017‐2020 data for community‐dwelling beneficiaries enrolled in TM and MA. We estimated difference‐in‐differences (DiD) models to examine changes in incident dementia diagnosis rates in MA relative to TM before and after 2019. The rate of incident dementia diagnosis in each year among beneficiaries without any dementia diagnosis in the year prior to the year of interest. Results There were 84,997,374 beneficiaries. In regression models that adjusted for beneficiary characteristics and time trends, we find that in response to the payment change, the annual incident dementia diagnosis rates in MA increased by about 0.282 percentage points or 11.5% relative to TM. We further find that the increase in incident dementia diagnosis was concentrated among beneficiaries who were more likely to have undiagnosed dementia, specifically, beneficiaries who were Hispanic or Black, who were ages 85 and over, and who were dual‐eligible/low‐income subsidy. Sensitivity analyses excluding 2020 data and allowing beneficiaries to switch between TM and MA during our sample years finds similar results. Conclusion Financial incentives to detect dementia resulted in more dementia diagnoses, particularly among persons at high risk of dementia and of undetected dementia but also raises concerns about diagnostic upcoding and the potential for over‐diagnosis.
Key findings
- The objective of this project is to examine the changes in annual incident dementia diagnoses rates associated with the inclusion of dementia diagnoses in risk adjustment models for Medicare Advantage.
- Results There were 84,997,374 beneficiaries.
- Sensitivity analyses excluding 2020 data and allowing beneficiaries to switch between TM and MA during our sample years finds similar results.
Why it matters
This study found that new dementia diagnoses in Medicare Advantage increased after dementia was added to the risk adjustment model for plan payments in 2019. It is about diagnosis coding and payment incentives, not about treating, curing, or preventing Alzheimer's disease.
Study details
- Effect sizeor 11.5
- Evidence strengthLow
How this study scored 33/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Julie Zissimopoulos: h-index 36 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Southern California: institution h-index 1,521 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 33 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Haye, S., Jacobson, M., Joyce, G., & Zissimopoulos, J. (2024). Changes to Medicare Advantage Risk Adjustment and Dementia Diagnosis in Older Adults. Alzheimer s & Dementia. https://doi.org/10.1002/alz.089359
Vancouver
Haye S, Jacobson M, Joyce G, Zissimopoulos J. Changes to Medicare Advantage Risk Adjustment and Dementia Diagnosis in Older Adults. Alzheimer s & Dementia. 2024. doi:10.1002/alz.089359.
BibTeX
@article{haye2024-a3d5dc30,
author = {Haye, Sidra and Jacobson, Mireille and Joyce, Geoffrey and Zissimopoulos, Julie},
title = {{Changes to Medicare Advantage Risk Adjustment and Dementia Diagnosis in Older Adults}},
journal = {Alzheimer s \& Dementia},
year = {2024},
doi = {10.1002/alz.089359},
url = {https://doi.org/10.1002/alz.089359}
}
Related studies in Health systems and care delivery
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.